Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1836)
All Articles published online
|
Publishing Process of This Article
|
Sep 16, 2023 (publication date) through Jun 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Weng XT, Lin WL, Pan QM, Chen TF, Li SY, Gu CM. Aggressive variant prostate cancer: A case report and literature review. World J Clin Cases 2023; 11(26): 6213-6222 [PMID: 37731555 DOI: 10.12998/wjcc.v11.i26.6213] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i26/6213.htm |
| Number | Citing Articles |
| 1 |
Han-Wei Ke, Wei-Yu Zhang, Ke-Xin Xu. Letter to the editor: Aggressive variant prostate cancer: An exemplary case study and comprehensive literature survey. World Journal of Clinical Cases 2023; 11(35): 8431-8433 doi: 10.12998/wjcc.v11.i35.8431
Abstract(1121) |
Core Tip(196) |
Full Article(HTML)(535)
|
Full Article with Cover (PDF)-1592K(74)
|
Full Article (Word)-103K(15)
|
Audio-467K(1)
|
Peer-Review Report-180K(23)
|
Answering Reviewers-3K(20)
|
Full Article (PDF)-326K(41)
|
Full Article (XML)-19K(23)
|
Times Cited (0)
|
Total Visits (2384)
|
Open
|
| 2 |
Yusuke Hoshino, Kent Kanao, Yu Miyama, Takeo Kosaka, Go Kaneko, Suguru Shirotake, Masanori Yasuda, Masafumi Oyama. Aggressive variant prostate cancer with multiple subcutaneous metastases: a case report. International Cancer Conference Journal 2024; doi: 10.1007/s13691-024-00673-7
|
| 3 |
Mohamed Wishahi. Treatment-induced neuroendocrine prostate cancer and <i>de novo</i> neuroendocrine prostate cancer: Identification, prognosis and survival, genetic and epigenetic factors. World Journal of Clinical Cases 2024; 12(13): 2143-2146 doi: 10.12998/wjcc.v12.i13.2143
|